EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 16 November 2017

#WeWontRest

Disease never stops, so neither do we

UP TO 3 MILLION DEATHS ARE AVOIDED EACH YEAR THANKS TO VACCINES

Disease never stops, so neither do we. Medical innovation needs to be one step ahead so that breakthroughs can be made. And we won't rest until we've helped make the world a healthier place for everyone.

#WeWontRest Read more

News

13112017 EFPIA DG reiterates the importance of putting patients at the centre of the EMA relocation...
13 November 2017

Nathalie Moll underlines the importance that this decision is made on the basis of essential and objective criteria... Read more

13112017 EFPIA Welcomes the Review Report Directive 2010/63/EU and Stresses the Importance...
13 November 2017

The pharmaceutical industry together with its research partners is investing significant efforts to fully integrate... Read more

16112017 EFPIA and its Specialised Groups Reiterate their Commitment to Tackling AMR
16 November 2017

Only a collaborative approach will allow us to make significant inroad in the many common areas, including pharmaceuticals... Read more

Blogs

14112017 Collaboration: The key to diabetes
14 November 2017 - Elias Zerhouni

A blog by Dr. Elias Zerhouni, President R&D, Sanofi Read more

10112017 Incentives, IP and smaller companies – the story of Chiesi and Holostem
10 November 2017

IP rights and EU pharmaceutical incentives enable ongoing innovation for patients Read more

Videos

EFPIA President Dr. Stefan Oschmann makes a video pledge for the European Antibiotic Awareness Day 2017
Tackling AMR requires collaboration between all stakeholders: governments, human and animal health industries, healthcare... Read more

Vaccines Europe President Pascale Mauran makes a video pledge for the European Antibiotic Awareness Day 2017
Being vaccinated reduces the potential misuse of antibiotics by preventing viral diseases for which antibiotics are... Read more

What we are reading

EU health Commissioner Vytenis Andriukaitis discusses Europe’s superbug battlefront
On 13 November 2017 (EurActiv)

By 2050, anti-microbial resistance (AMR) could kill more European citizens than cancer. Vytenis Andriukaitis, European... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu